Need for a paradigm shift: the importance of risk factor reduction therapy in treating patients with cardiovascular disease

Cardiovascular disease remains the number one killer in the United States, despite advances made in diagnosis and therapy. A major shift to expand treatment beyond symptomatic obstructions and infarctions toward comprehensive therapies aimed at treatment